A Retrospective Analysis of Real Life Medication Regimens for Adults with Atopic Dermatitis on Immunosuppressive Medication (Ramadil) In a Single Third Line Center in Belgium

Abstract

Muyldermans C, Vanhoutvin T, Garmyn M, De Haes P, Van Laethem A, Van Aerde E Mertens S and Morren MA

Few Belgian data are available on the treatment of severe atopic dermatitis in adults. As in most other countries, only cyclosporine A is registered for the systemic treatment of atopic dermatitis. Although treatment periods are restricted, side effects may occur, and response failure is possible. Small trials with other immunosuppressive drugs (azathioprine, mofetylmycophenolate, and methotrexate) have indicated they may improve atopic dermatitis, although their effect is slower than with cyclosporine. In the future, treatment of atopic dermatitis may drastically change as the therapeutic effects of new biologicals are promising. This RAMADIL study, from a third line referral center in Belgium, was conducted in order to collect information about the way AD is treated in this pre-biological era.

PDF